Effects of carnosine on prooxidant-antioxidant status in heart tissue, plasma and erythrocytes of rats with isoproterenol-induced myocardial infarction

被引:38
作者
Evran, Betul [1 ]
Karpuzoglu, Hande [1 ]
Develi, Seval [1 ]
Kalaz, Esra Batul [1 ]
Soluk-Tekkesin, Merva [2 ]
Olgac, Vakur [2 ]
Dogru-Abbasoglu, Semra [1 ]
Uysal, Mujdat [1 ]
机构
[1] Istanbul Univ, Istanbul Fac Med, Dept Biochem, Istanbul, Turkey
[2] Istanbul Univ, Inst Oncol, Dept Pathol, Istanbul, Turkey
关键词
Carnosine; Myocardial infarction; Isoproterenol; Oxidative stress; Rats; CARDIAC MARKER ENZYMES; LIPID-PEROXIDATION; OXIDATIVE STRESS; LIVER-INJURY; URSOLIC ACID; TROPONIN-I; LIPOPROTEINS; HISTIDINE; BALANCE; SERUM;
D O I
10.1016/j.pharep.2013.08.008
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Rats were injected with isoproterenol (ISO; 110 mg/kg, ip, 2 doses, 24 h interval) to induce acute myocardial infarction (AMI) and were sacrificed 6 and 24 h after the last ISO injection. The heart tissue, plasma and erythrocytes of these rats were evaluated for cardiac markers and oxidative stress parameters. Levels of cardiac troponin T (cTnT) and the activities of creatine kinase (CK), lactate dehydrogenase (LDH), and aspartate aminotransferase (AST) in plasma were increased 6 and 24 h after ISO treatment. The levels of malondialdehyde (MDA), diene conjugate (DC), and protein carbonyl (PC) were increased in heart tissue and plasma, while levels of erythrocyte MDA and glutathione (GSH) and plasma ferric reducing antioxidant power (FRAP) were also increased. However, GSH levels and the activities of superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) decreased in heart tissue of rats with AMI. We also investigated the effects of carnosine (CAR) treatment on these parameters 24 h after the last ISO injection. CAR (250 mg/kg/day; ip) treatments were carried out either 10 days before ISO injection or 2 days concomitant with ISO. Pretreatment with CAR decreased plasma LDH and AST activities and ameliorated cardiac histopathological changes in ISO-treated rats. Cardiac MDA, DC and PC levels decreased, but GSH levels and SOD and GSH-Px activities increased. However, the increases in plasma MDA and PC levels as well as erythrocyte H2O2-induced MDA and GSH levels did not change due to CAR pretreatment. In conclusion, our findings indicate that CAR pretreatment may have protective effects on ISO-induced cardiac toxicity by decreasing oxidative stress. (C) 2014 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.
引用
收藏
页码:81 / 86
页数:6
相关论文
共 44 条
[1]   Carnosine and related dipeptides as quenchers of reactive carbonyl species: From structural studies to therapeutic perspectives [J].
Aldini, G ;
Facino, RM ;
Beretta, G ;
Carini, M .
BIOFACTORS, 2005, 24 (1-4) :77-87
[2]   The carbonyl scavenger carnosine ameliorates dyslipidaemia and renal function in Zucker obese rats [J].
Aldini, Giancarlo ;
Orioli, Marica ;
Rossoni, Giuseppe ;
Savi, Federica ;
Braidotti, Paola ;
Vistoli, Giulio ;
Yeum, Kyung-Jin ;
Negrisoli, Gianpaolo ;
Carini, Marina .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2011, 15 (06) :1339-1354
[3]   The effect of carnosine pretreatment on oxidative stress and hepatotoxicity in binge ethanol administered rats [J].
Artun, B. C. ;
Kusku-Kiraz, Z. ;
Gulluoglu, M. ;
Cevikbas, U. ;
Kocak-Toker, N. ;
Uysal, M. .
HUMAN & EXPERIMENTAL TOXICOLOGY, 2010, 29 (08) :659-665
[4]   The effect of carnosine treatment on prooxidant-antioxidant balance in liver, heart and brain tissues of male aged rats [J].
Aydin, A. F. ;
Kucukgergin, C. ;
Ozdemirler-Erata, G. ;
Kocak-Toker, N. ;
Uysal, M. .
BIOGERONTOLOGY, 2010, 11 (01) :103-109
[5]  
Aydin AF, 2010, PHARMACOL REP, V62, P733
[6]   Carnosine derivatives: new multifunctional drug-like molecules [J].
Bellia, Francesco ;
Vecchio, Graziella ;
Rizzarelli, Enrico .
AMINO ACIDS, 2012, 43 (01) :153-163
[7]   The ferric reducing ability of plasma (FRAP) as a measure of ''antioxidant power'': The FRAP assay [J].
Benzie, IFF ;
Strain, JJ .
ANALYTICAL BIOCHEMISTRY, 1996, 239 (01) :70-76
[8]  
BEUTLER E, 1963, J LAB CLIN MED, V61, P882
[9]  
Boldyrev AA, 2005, ANN NY ACAD SCI, V1057, P1, DOI DOI 10.1196/ANNALS.1356.013
[10]  
Buege J A, 1978, Methods Enzymol, V52, P302